Scarica l'app Stockscreener
5.79
3.02%
-0.18
Dopo l'orario di chiusura:
5.81
0.02
+0.35%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MNKD Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.97
Aprire:
$5.97
Volume 24 ore:
2.80M
Relative Volume:
1.03
Capitalizzazione di mercato:
$1.60B
Reddito:
$248.37M
Utile/perdita netta:
$11.74M
Rapporto P/E:
115.80
EPS:
0.05
Flusso di cassa netto:
$18.24M
1 W Prestazione:
-3.98%
1M Prestazione:
-9.95%
6M Prestazione:
+0.52%
1 anno Prestazione:
+73.35%
Intervallo 1D:
$5.75
$5.98
Intervallo di 1 settimana:
$5.75
$6.23
Portata 52W:
$3.17
$7.63
Mannkind Corp Stock (MNKD) Company Profile
Nome
Mannkind Corp
Settore
Industria
Telefono
818-661-5000
Indirizzo
1 CASPER STREET, DANBURY, CA
Confronta MNKD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MNKD
Mannkind Corp
|
5.79 | 1.60B | 248.37M | 11.74M | 18.24M | 0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Mannkind Corp Stock (MNKD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-20 | Iniziato | Wells Fargo | Overweight |
| 2024-12-19 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-09-09 | Ripresa | Leerink Partners | Outperform |
| 2024-06-13 | Iniziato | Rodman & Renshaw | Buy |
| 2023-10-10 | Iniziato | Wedbush | Outperform |
| 2021-05-14 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-12-24 | Iniziato | Oppenheimer | Outperform |
| 2019-10-25 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-05-14 | Iniziato | BTIG Research | Buy |
| 2019-03-04 | Iniziato | SVB Leerink | Outperform |
| 2019-02-22 | Iniziato | SVB Leerink | Outperform |
| 2018-02-28 | Downgrade | Maxim Group | Hold → Sell |
| 2017-11-01 | Downgrade | Maxim Group | Buy → Hold |
| 2017-10-10 | Iniziato | H.C. Wainwright | Buy |
| 2017-10-06 | Reiterato | Maxim Group | Buy |
| 2017-08-11 | Iniziato | Maxim Group | Buy |
| 2016-05-10 | Reiterato | Piper Jaffray | Underweight |
| 2016-05-10 | Reiterato | RBC Capital Mkts | Underperform |
| 2016-01-06 | Reiterato | Piper Jaffray | Underweight |
| 2016-01-06 | Reiterato | RBC Capital Mkts | Underperform |
| 2015-11-04 | Downgrade | RBC Capital Mkts | Outperform → Underperform |
| 2015-09-09 | Downgrade | Piper Jaffray | Neutral → Underweight |
| 2015-08-03 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-05-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2015-05-11 | Reiterato | MLV & Co | Hold |
| 2015-04-16 | Reiterato | RBC Capital Mkts | Outperform |
Mostra tutto
Mannkind Corp Borsa (MNKD) Ultime notizie
MannKind Co. (NASDAQ:MNKD) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Cantor Fitzgerald Estimates MannKind FY2025 Earnings - Defense World
MannKind (NASDAQ:MNKD) Shares Down 3.1%Should You Sell? - MarketBeat
MannKind Co. (NASDAQ:MNKD) Sees Large Drop in Short Interest - MarketBeat
International Assets Investment Management LLC Has $86,000 Position in MannKind Co. (NASDAQ:MNKD) - Defense World
MannKind appoints new EVP as executive plans retirement - Investing.com
MannKind Expands Executive Leadership Team - Yahoo Finance
Here’s Why MannKind Corporation (NASDAQ:MNKD) Is Among the Best Diabetes Stocks to Buy Under $10 - Insider Monkey
10 Best Diabetes Stocks To Buy Under $10 - Insider Monkey
MannKind Announces Upcoming Retirement of Lauren Sabella - TipRanks
MannKind expecting to ‘practically double in size’ with new hires in Danbury - Westfair Online
MannKind Co. (NASDAQ:MNKD) Receives $8.88 Average PT from Analysts - MarketBeat
MannKind Co. (NASDAQ:MNKD) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Franklin Resources Inc. Buys 4,603 Shares of MannKind Co. (NASDAQ:MNKD) - Defense World
Geode Capital Management LLC Has $39.88 Million Stock Holdings in MannKind Co. (NASDAQ:MNKD) - Defense World
MannKind Target of Unusually High Options Trading (NASDAQ:MNKD) - Defense World
MannKind (NASDAQ:MNKD) Stock Price Down 3.1%What's Next? - MarketBeat
Barclays PLC Buys 338,121 Shares of MannKind Co. (NASDAQ:MNKD) - Defense World
Barclays PLC Purchases 338,121 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
Exploring 3 High Growth Tech Stocks In The United States - Yahoo Finance
MannKind (NASDAQ:MNKD) Research Coverage Started at Wells Fargo & Company - Defense World
FY2025 EPS Estimates for MannKind Lowered by Leerink Partnrs - MarketBeat
Leerink Partnrs Decreases Earnings Estimates for MannKind - Defense World
Wells Fargo Initiates Coverage of MannKind (MNKD) with Overweight Recommendation - MSN
MannKind stock up 10% amid bullish Wells Fargo note - MSN
MannKind (NASDAQ:MNKD) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
MannKind (NASDAQ:MNKD) pulls back 3.8% this week, but still delivers shareholders fantastic 36% CAGR over 5 years - Yahoo Finance
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
RBC Capital Upgrades MannKind (MNKD) - MSN
MannKind (NASDAQ:MNKD) Trading Up 5.7%Here's Why - MarketBeat
3 High-Growth Biotech Stocks to Watch - Inkl
MannKind (NASDAQ:MNKD) Upgraded to Outperform at Royal Bank of Canada - MarketBeat
Tyvaso DPI royalties and pipeline potential boost MannKind stock—RBC - Investing.com
Noteworthy Wednesday Option Activity: MNKD, BTU, FSLR - Nasdaq
MannKind (NASDAQ:MNKD) Shares Gap UpShould You Buy? - MarketBeat
MannKind to issue shares in debt exchange deal - Investing.com
MannKind to issue shares in debt exchange deal By Investing.com - Investing.com Canada
MannKind trims debt with $194 million note exchange By Investing.com - Investing.com Canada
MannKind to reduce debt by 84% - MSN
MannKind trims debt with $194 million note exchange - Investing.com
MannKind Slashes Debt by 84% in Major Financial Restructuring, Converts $194M Notes to Equity - StockTitan
HighTower Advisors LLC Buys 107,560 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
MannKind (NASDAQ:MNKD) Stock Price Down 5.4%Here's Why - MarketBeat
MannKind Becomes Oversold (MNKD) - Nasdaq
Wellington Management Group LLP Acquires 85,977 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®) - Barchart
Mannkind Corp (MNKD-Q) QuotePress Release - The Globe and Mail
MannKind Announces Six-Month Results From Phase 3 - GlobeNewswire
The Manufacturers Life Insurance Company Grows Stake in MannKind Co. (NASDAQ:MNKD) - Defense World
Cipla’s ‘inhaled insulin’ from US’ MannKind Corp adds a ‘layer of convenience’ for those with diabetes - BusinessLine
CDSCO approves Cipla to distribute, market inhaled insulin in India - Daijiworld.com
Mannkind Corp Azioni (MNKD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.95%
2.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):